Franco-Nevada Down Nearly 7%, on Pace for Largest Percent Decrease Since March 2020 — Data Talk
Franco-Nevada Corporation (FNV) is currently at $127.93, down $9.54 or 6.94%
--Would be lowest close since Feb. 28, 2023, when it closed at $127.57
--On pace for largest percent decrease since March 27, 2020, when it fell 8.5%
--Currently down four of the past five days
--Down 4.17% month-to-date
--Down 6.26% year-to-date; on pace for worst year since 2018, when it fell 12.23%
--Down 23.86% from its all-time closing high of $168.01 on April 20, 2022
--Up 3.52% from 52 weeks ago (Oct. 31, 2022), when it closed at $123.58
--Down 20.25% from its 52-week closing high of $160.42 on May 9, 2023
--Up 8.71% from its 52-week closing low of $117.68 on Nov. 3, 2022
--Traded as low as $123.80; lowest intraday level since Feb. 24, 2023, when it hit $122.33
--Down 9.94% at today's intraday low; largest intraday percent decrease since March 19, 2020, when it fell as much as 10.59%
All data as of 11:56:31 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 30, 2023 12:13 ET (16:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations